These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1347231)

  • 41. [Evaluation of the degree of muscle blockade: a comparative study using electromyography of the muscular relaxation induced by pancuronium, atracurium and vecuronium].
    Cabarrocas E; Roigé J; Durán L; Gancedo V; Ballvé M; Martínez Bayón MJ
    Rev Esp Anestesiol Reanim; 1990; 37(3):137-41. PubMed ID: 1975113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the power spectrum of the evoked compound action potential of the adductor pollicis with the onset of neuromuscular blockade.
    Harper NJ; Pugh ND; Healy TE; Petts HV
    Br J Anaesth; 1987 Feb; 59(2):200-5. PubMed ID: 2881566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions.
    Fawcett WJ; Dash A; Francis GA; Liban JB; Cashman JN
    Acta Anaesthesiol Scand; 1995 Apr; 39(3):288-93. PubMed ID: 7793202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients.
    Slavov V; Khalil M; Merle JC; Agostini MM; Ruggier R; Duvaldestin P
    Br J Anaesth; 1995 Jun; 74(6):709-11. PubMed ID: 7640130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency of train-of-four stimulation influences neuromuscular response.
    Meretoja OA; Taivainen T; Brandom BW; Wirtavuori K
    Br J Anaesth; 1994 Jun; 72(6):686-7. PubMed ID: 7912949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Atracurium, vecuronium and pancuronium. Results of a polygraphic study].
    Bifarini G; Tesoro S; Favetta P; Cirulli P; Paoletti F; Ciammitti C
    Minerva Anestesiol; 1989 Nov; 55(11):457-62. PubMed ID: 2576684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recovery of neuromuscular function and postoperative morbidity following blockade by atracurium, alcuronium and vecuronium.
    Kong KL; Cooper GM
    Anaesthesia; 1988 Jun; 43(6):450-3. PubMed ID: 2900608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of halothane on the train-of-four fade after atracurium in children.
    Woloszczuk-Gebicka B
    Br J Anaesth; 1990 Oct; 65(4):540-1. PubMed ID: 2174250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fade profiles during spontaneous offset of neuromuscular blockade: vecuronium and gallamine compared.
    Power SJ; Pearce AC; Jones RM
    Br J Anaesth; 1988 Apr; 60(5):486-90. PubMed ID: 2897861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potency of atracurium and vecuronium at the diaphragm and the adductor pollicis muscle.
    Laycock JR; Donati F; Smith CE; Bevan DR
    Br J Anaesth; 1988 Sep; 61(3):286-91. PubMed ID: 2902872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histamine release during the administration of atracurium or vecuronium in children.
    Goudsouzian NG; Young ET; Moss J; Liu LM
    Br J Anaesth; 1986 Nov; 58(11):1229-33. PubMed ID: 2430606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
    Gramstad L
    Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of H2-receptor antagonist pretreatment on vecuronium- and atracurium-induced neuromuscular block.
    McCarthy G; Mirakhur RK; Elliott P; Wright J
    Br J Anaesth; 1991 Jun; 66(6):713-5. PubMed ID: 1676594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tetanic fade during recovery from vecuronium block: comparison of systemic and isolated forearm administration.
    Campkin NT; Hood JR; Feldman SA
    Br J Anaesth; 1993 May; 70(5):581-2. PubMed ID: 8100441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does vecuronium accumulate in the renal transplant patient?
    Starsnic MA; Goldberg ME; Ritter DE; Marr AT; Sosis M; Larijani GE
    Can J Anaesth; 1989 Jan; 36(1):35-9. PubMed ID: 2563340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A contribution to the monitoring of neuromuscular blockade: an evaluation of the Datex Relaxograph.
    Mortier E; Rolly G
    Acta Anaesthesiol Belg; 1989; 40(2):123-6. PubMed ID: 2572137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postoperative residual block after intermediate-acting neuromuscular blocking drugs.
    Hayes AH; Mirakhur RK; Breslin DS; Reid JE; McCourt KC
    Anaesthesia; 2001 Apr; 56(4):312-8. PubMed ID: 11284816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of succinylcholine on neuromuscular transmission during recovery from vecuronium].
    Miyamoto M; Hirai H; Fujimoto K; Yurino M; Ogawa H
    Masui; 1994 Apr; 43(4):487-91. PubMed ID: 7910644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.